Clinical Trial Update: Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Anifrolumab in adults with active proliferative lupus nephritis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Anifrolumab (anifrolumab)

Snippet

Sponsor: AstraZeneca | Conditions: Lupus Nephritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING